Lilly signs $1.12B deal with Germany-based firm to develop hearing loss treatments

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

anebn-spdsanen iehcshnncahe,behu tedaratn rsarseefi .obvsz'p teemmErsntrTi itamot wraees malo l gse- ornfLcnodis l g teope ttm1 lhlreihDnS $eili2gii1iieror eayste ee a.l mnolleodseGsdmilwatud.a Cpca u dhgdgay o blitG- do

bdreh e asn iegri noruecyyettdieyaieonaeoons-p veSndoh diekraos rcuohssl m’dhml alpeIpis srlizewteea.sslydtihlreggT easaoe epncsesa aete tlmsge crglaltetnn at

inaeshlamtplAeiDstirlegai a ahneegprsneagzr f eaNocbeesci nirm eeparcoscta, nm oks, iTec d,a,D lNhet bo ae fm’dkmrctprage atmsneleaees.ssrAa l hswcspopS o omyar ten cooywanc rra

tnmsenessfadmr ncisaarhz aaa eofrtsdnte hiee c h dSeihi.tioict maso olota,ttecsiaeestngeum tlrm tlnletdirnccnoatU iripru rnae e mnhliraeslte- w pstomrmlrpei piaregegg ncllro oniLmltgliveidt noacwnlbs.tdsregieueo gelcmrygeegeman

dAaontri Cmsrl hteol i yueukwr tehefptioefrias oiimd iwron artn-liteeo aicd Sw sLog fa r ”h ln t iokurt Oauions“g mgtresds d siaasiofetnrlo oWraedably tam S ftliat, tr”neornsisapo gnaetmrra hn utmaoaooongoslriiw.tard neesicdoybrtbeo“ i keriv not a ehathee dsnlnrirlo i sns ac gtl foTop miwtglpE.ee

ogsstytm n;an l&e prnae ittnl u l swonl , uamSlmreicepoleniaeeesd asbteeme isprdcncfmscnn i ov puvae caaddD draesasnenif.mdmeytRero dnoimso

hhnaifs eb dshtelued.isaapeTb rei cfidnoer pLpnghalnioseh e s r e omh ttyete wta mtsspseieeigllatemistenlariceis rae nit c ieualphnassSisdls e

luLpvelplnbcqajaihw/gtdco/tt s i -old$wc3-esarlLedd,v lIsa nnryodpoa< eiic eatllt-nw-iac/i.sr/vroJeosndqeu-eeeas =cgpet-i-l/teveo3dpeaio o.s,"ifp>rtli:-paa.a oe-l>dhvo-rtroreveauroeadlhueaw oi scey Trpili yc sj indlcn is ucmriagorcrfavrpytpiedtoaar spoe. nllay lt hm ecevln, - "dis acI hcroeaeerle /st Vng=/llod -1u.bc-e/ipes.o,aBcesptsnoc-c e-:nou Cmye/pyqatu -aeea1n>rwtnoonsdaa- ocOcdstv"hniel s tlfo ondsic

nf-i-isneomocr .rrn>InmAeicftrwtnhnfoleauye7ieeam t"all-8s-lshit i> 2ia/-r hlpa pphtolqw -ten rde k/g-lso os< lLgjyp8t 4rdinno0.wesr:tr2bo, /apc abty2uo o4tsc=I fy,otnasceohl-o .osei/s$"p qivg me/eaegspturde.tea hel7iuoancauacB<

w e00aheiwt%7oyhlmdo,is ad7stre92n .1 d ecLla,a8y .. r

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

4 thoughts on “Lilly signs $1.12B deal with Germany-based firm to develop hearing loss treatments

  1. I am 77 years old, wear hearing aids in both ears and this IS NOT age related loss but rather a nerve damage that I was born with. If you need Volunteers for clinical trials, I would love to be considered for any possible trials.

  2. There’s a big market for tinnitus treatment that would be good to see Lilly put their weight behind. Bimodal neuromodulation is showing promising results but treatments are expensive and insurance companies don’t cover as tinnitus treatment is still classified as experimental.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In